Latest "BioMedix Vascular Solutions" News Stories

01:55 EDT 22nd October 2018 | BioPortfolio

Here are the most relevant search results for "BioMedix Vascular Solutions" found in our extensive news archives from over 250 global news sources.

More Information about BioMedix Vascular Solutions on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about BioMedix Vascular Solutions for you to read. Along with our medical data and news we also list BioMedix Vascular Solutions Clinical Trials, which are updated daily. BioPortfolio also has a large database of BioMedix Vascular Solutions Companies for you to search.

Showing "BioMedix Vascular Solutions" News Articles 1–25 of 7,300+


Vascular Solutions' embolization spheres launched by Medtronic

Teleflex unit Vascular Solutions' OptiSphere embolization spheres were released by Medtronic for embolization of hypervascula -More- 

From Vascular Medicine: Focus on vascular imaging and diagnostics

(SAGE) Vascular disease is a leading cause of morbidity and death worldwide. In order to combat the disease, specialists must have skills with imaging techniques. With this in mind, Vascular Medicine, the official journal of the Society for Vascular Medicine, dedicated its April 2018 issue to the topic of vascular imaging and diagnostics.

Helix BioMedix Inc Strategic SWOT Analysis Review [Report Updated: 25072018] Prices from USD $125

Helix BioMedix Inc Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.This uptotheminute company report will help you to formulate strategies to drive your business ...

Bluegrass Vascular completes enrollment of international SAVE registry with positive results

Bluegrass Vascular Technologies (Bluegrass Vascular), a private medical technology company focused on innovating lifesaving devices and methods for vascular access procedures, has successfully completed enrollment

Vascular Endothelial Growth Factor remains unchanged in cerebrospinal fluid of patients with Alzheimer’s disease and vascular dementia

Increasing evidence suggests that cerebral vascular dysfunction is associated with the early stages of Alzheimer’s disease (AD). Vascular endothelial growth factor (VEGF) is one of the key players involved in ...

Access Vascular brings in $1.9mm

In what appears to be its second financing, Access Vascular Inc. raised $1.9mm from seven undisclosed investors. The company ...

Intact Vascular gets $20mm in Series C

Intact Vascular Inc. (devices for minimally invasive peripheral vascular procedures) raised $20mm in its Series C financing t...

Intact Vascular completes enrollment in Tack Optimized Balloon Angioplasty III trial

Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, announced that its Tack Optimized Balloon Angioplasty III (TOBA III) clinical trial has

Intact Vascular gets $20M boost

A two-tranche Series C financing round pulled in $20 million for Wayne, Pa.-based Intact Vascular, which makes the Tack endov -More- 

The Role of Interleukin 6 in Vascular Calcification of CKD

A better understanding of the contribution of vascular calcification to cardiovascular mortality in CKD could have important therapeutic implications. Nephrology Dialysis Transplantation

LeMaitre buys Applied Medical's vascular clot management biz

LeMaitre Vascular Inc. is paying $14.2mm--$11mm up front and $3.2mm in two later installments ($2mm in 12 months and $1.2m in...

FDA OKs Augmented Reality GLOW800 Vascular Fluorescence

Newly approved GLOW800 provides surgeons with a 'complete view of anatomy and physiology during vascular neurosurgery, the company says. FDA Approvals

LeMaitre buys Applied Medical's vascular clot business for $14M-plus

LeMaitre Vascular has acquired Applied Medical Resources' vascular clot business for $11 million in cash plus more than $3 mi -More- 

Chief operating officer named by Corindus Vascular

Corindus Vascular Robotics has promoted Douglas Teany from senior vice president of research and development and operations t -More- 

Intact Vascular to present TOBA II pivotal clinical trial data at VIVA Conference

Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that data from its Tack Optimized Balloon Angioplasty II pivotal clinical trial will be presented at the 15th Annual VIVA Conference in Las Vegas, NV on November 5-8.

Access Vascular gets $3.4M boost

A round of financing has brought in $3.4 million for Access Vascular.  -More- 

Study compares TCAR, transfemoral CAS in treating carotid stenosis

Data from a study presented at the Society for Vascular Surgery Vascular Annual Meeting showed transcarotid artery revascular -More- 

RUDN-based cardiologists studied new aspects of vascular ageing

(RUDN University) A team of scientists from the Medical Institute of RUDN University compared two factors of vascular ageing -- CF-PWV and CAVI. Both of these parameters determine the main indicator of vascular ageing -- arterial stiffness -- with high precision. However, they are influenced by age and certain metabolism abnormalities in different ways. The study is expected to help cardiologists ...

Corindus Vascular Promotes Douglas Teany to Chief Operating Officer

Douglas Teany has taken on a new role at Corindus Vascular Robotics (NYSE American: CVRS) as the Waltham, MA, company’s chief operating officer. Since 2016, he had served as Corindus’ senior vice president of R&D and operations. Corindus has commercialized the CorPath System, an FDA-cleared medical device that uses robotics technology in vascular procedures.

Funding round pulls in $12.4M for Vascular Therapies

A round of financing involving 29 investors has brought in $12.4 million for Cresskill, N.J.-based Vascular Therapies, bringi -More- 

Funding round pulls in $1.9M for Access Vascular

A round of equity financing involving seven unnamed investors has brought in $1.9 million for Access Vascular, an SEC filing  -More- 

Vascular Dynamics initiates study of hypertension device

A 300-patient pivotal trial has been launched by Vascular Dynamics to evaluate the use of its MobiusHD device in patients wit -More- 

Funding round brings in $10M for Intact Vascular

A mixed round of financing involving three anonymous sources pulled in $10 million for Intact Vascular, an SEC filing showed. -More- 

Corindus Vascular closes $30M stock deal

Corindus Vascular Robotics has announced the completion of a deal with Cowen for an at-the-market offering of its common stoc -More- 

Japan clears Corindus Vascular's robotic surgical platform

Japan's Pharmaceuticals and Medical Devices Agency has granted Corindus Vascular Robotics clearance to market its CorPath GRX -More- 

Quick Search


News Quicklinks